Patents by Inventor Milton J. Cormier

Milton J. Cormier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant DNA vectors capable of expressing apoaequorin
    Patent number: 5798441
    Abstract: A gene which codes for the protein apoaequorin is disclosed along with recombinant DNA vectors containing this gene. Homogeneous peptides having the bioluminescence properties of natural, mixed apoaeqorin are also disclosed.
    Type: Grant
    Filed: November 29, 1994
    Date of Patent: August 25, 1998
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Milton J. Cormier, Douglas Prasher
  • Recombinant DNA vectors capable of expressing apoaequorin
    Patent number: 5766941
    Abstract: A gene which codes for the protein apoaequorin is disclosed along with recombinant DNA vectors containing this gene. Homogeneous peptides having the bioluminescence properties of natural, mixed apoaeqorin are also disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 16, 1998
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Milton J. Cormier, Douglas Prasher
  • Recombinant DNA vectors capable of expressing apoaequorin
    Patent number: 5744579
    Abstract: A gene which codes for the protein apoaequorin is disclosed along with recombinant DNA vectors containing this gene. Homogeneous peptides having the bioluminescence properties of natural, mixed apoaequorin are also disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 28, 1998
    Assignee: University of Georgia Research Foundation
    Inventors: Milton J. Cormier, Douglas Prasher
  • Recombinant DNA vectors capable of expressing apoaequorin
    Patent number: 5422266
    Abstract: A gene which codes for the protein apoaequorin is disclosed alone with recombinant DNA vectors containing this gene. Homogeneous peptides having the bioluminescence properties of natural, mixed apoaeqorin are also disclosed.
    Type: Grant
    Filed: October 9, 1992
    Date of Patent: June 6, 1995
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Milton J. Cormier, Douglas Prasher
  • Isolated Renilla luciferase and method of use thereof
    Patent number: 5418155
    Abstract: Genetic material encoding luciferase from the marine coelenterate Renilla has been isolated and characterized. This genetic material allows the production of peptides for use as labels in bioluminescence assays or can itself be directly used to identify luciferase genes from related organisms.
    Type: Grant
    Filed: December 14, 1993
    Date of Patent: May 23, 1995
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Milton J. Cormier, William W. Lorenz
  • Cloning and expressions of Renilla luciferase
    Patent number: 5292658
    Abstract: Genetic material encoding luciferase from the marine coelenterate Renilla has been isolated and characterized. This genetic material allows the production of peptides for use as labels in bioluminescence assays or can itself be directly used to identify luciferase genes from related organisms.
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: March 8, 1994
    Assignee: University of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center
    Inventors: Milton J. Cormier, William W. Lorenz
  • Recombinant DNA vectors capable of expressing apoaequorin in E. coli
    Patent number: 5162227
    Abstract: A gene which codes for the protein apoaequorin is disclosed along with recombinant DNA vectors containing this gene.
    Type: Grant
    Filed: March 17, 1988
    Date of Patent: November 10, 1992
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of phenothiazine 5-oxide drugs as vaginal contraceptives
    Patent number: 4578379
    Abstract: The use of phenothiazine 5-oxide drugs as vaginal contraceptives is disclosed. The invention may be implemented by incorporating an effective amount of a phenothiazine 5-oxide drug in a known method such as jelly, foam, or suppository introduction means for use prior to intercourse.
    Type: Grant
    Filed: November 30, 1984
    Date of Patent: March 25, 1986
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of phenothiazine 5-oxide drugs in uterus to prevent pregnancy
    Patent number: 4578385
    Abstract: The use of phenothiazine 5-oxide drugs by injecting or introducing such drugs directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drugs are disclosed, such as by mixing such drugs with jelly carriers, foam carriers, or paraffin oil.
    Type: Grant
    Filed: November 13, 1984
    Date of Patent: March 25, 1986
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of N-(6 aminohexyl)-5-chloro-1-naphthalenesulfonamide, N-(6 aminohexyl)-5-chloro-2-naphthalenesulfonamide, and N-(6 aminohexyl)-5-bromo-2-naphthalenesulfonamide as vaginal contraceptives
    Patent number: 4476141
    Abstract: The use of N-(6 aminohexyl)-5-chloro-1-naphthalenesulfonamide, N-(6 aminohexyl)-5-chloro-2-naphthalenesulfonamide, N-(6 aminohexyl)-5-bromo-2-naphthalenesulfonamide as a vaginal contraceptive is disclosed. The invention may be implemented by incorporating the drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse.
    Type: Grant
    Filed: October 27, 1983
    Date of Patent: October 9, 1984
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of 9-anthroylcholine as a vaginal contraceptive
    Patent number: 4470995
    Abstract: The use of 9-anthroylcholine as a vaginal contraceptive is disclosed. The invention may be implemented by incorporating the drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse.
    Type: Grant
    Filed: October 27, 1983
    Date of Patent: September 11, 1984
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of N-phenyl-1-naphthylamine as a vaginal contraceptive
    Patent number: 4470996
    Abstract: The use of N-phenyl-1-naphthylamine as a vaginal contraceptive is disclosed. The invention may be implemented by incorporating the drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse.
    Type: Grant
    Filed: October 27, 1983
    Date of Patent: September 11, 1984
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of 8-anilino-1-naphthalenesulfonate as a vaginal contraceptive
    Patent number: 4444789
    Abstract: The use of 8-anilino-1-naphthalenesulfonate as a vaginal contraceptive is disclosed. The invention may be implemented by incorporating the drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse.
    Type: Grant
    Filed: July 14, 1982
    Date of Patent: April 24, 1984
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of psychoactive drugs as vaginal contraceptives
    Patent number: 4443446
    Abstract: The use of psychoactive drugs as vaginal contraceptives is disclosed. The invention may be implemented by incorporating a psychoactive drug in a known method such as jelly, foam, or suppository introduction means prior to intercourse. Furthermore, the use of psychoactive drugs after intercourse using the above methods is disclosed.
    Type: Grant
    Filed: May 30, 1980
    Date of Patent: April 17, 1984
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of 9-anthroylcholine in the uterus to prevent pregnancy
    Patent number: 4421764
    Abstract: The use of 9-anthroylcholine by injecting or introducing such drug directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drug are disclosed, such as by mixing such drug with jelly carriers, foam carriers, or paraffin oil.
    Type: Grant
    Filed: July 14, 1982
    Date of Patent: December 20, 1983
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of N-(6 aminohexyl)-5-chloro-1-naphthalenesulfonamide, N-(6 aminohexyl)-5-chloro-2-naphthalenesulfonamide, or N-(6 aminohexyl)-5-bromo-2-naphthalenesulfonamide in the uterus to prevent pregnancy
    Patent number: 4419366
    Abstract: The use of N-(6 aminohexyl)-5-chloro-1-naphthalenesulfonamide, N-(6 aminohexyl)-5-chloro-2-naphthalenesulfonamide, or N-(6 aminohexyl)-5-bromo-2-naphthalensulfonamide by injecting or introducing such drugs directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drugs are disclosed, such as by mixing such drugs with jelly carriers, foam carriers, or paraffin oil.
    Type: Grant
    Filed: July 14, 1982
    Date of Patent: December 6, 1983
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of 8-anilino-1-naphthalenesulfonate in the uterus to prevent pregnancy
    Patent number: 4416897
    Abstract: The use of 8-anilino-1-naphthalenesulfonate by injecting or introducing such drug directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drug are disclosed, such as by mixing such drug with jelly carriers, foam carriers, or paraffin oil.
    Type: Grant
    Filed: July 14, 1982
    Date of Patent: November 22, 1983
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of N-phenyl-1-naphthylamine in the uterus to prevent pregnancy
    Patent number: 4416900
    Abstract: The use of N-phenyl-1-naphthylamine by injecting or introducing such drug directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drug are disclosed, such as by mixing such drug with jelly carriers, foam carriers, or paraffin oil.
    Type: Grant
    Filed: July 14, 1982
    Date of Patent: November 22, 1983
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier
  • Use of psychoactive drugs in uterus to prevent pregnancy
    Patent number: 4377577
    Abstract: The use of psychoactive drugs by injecting or introducing such drugs directly into the uterus is disclosed as a means of preventing pregnancy after intercourse has occurred. Various means of introducing such drugs are disclosed, such as by mixing such psychoactive drugs with jelly carriers, foam carriers, or paraffin oil.
    Type: Grant
    Filed: July 6, 1981
    Date of Patent: March 22, 1983
    Assignee: University of Georgia Research Foundation, Inc.
    Inventor: Milton J. Cormier